351 related articles for article (PubMed ID: 30145910)
1. One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients.
Ibáñez-Muñoz A; Soto-Biforcos VS; Chacón-González M; Rúa-Galisteo O; Arrieta-Los Santos A; Lizuain-Abadía ME; Del Río Mayor JL
Eur J Ophthalmol; 2019 May; 29(3):309-314. PubMed ID: 30145910
[TBL] [Abstract][Full Text] [Related]
2. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.
Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B
Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702
[TBL] [Abstract][Full Text] [Related]
3. XEN implant in primary and secondary open-angle glaucoma: A 12-month retrospective study.
Ibáñez-Muñoz A; Soto-Biforcos VS; Rodríguez-Vicente L; Ortega-Renedo I; Chacón-González M; Rúa-Galisteo O; Arrieta-Los Santos A; Lizuain-Abadía ME; Del Río Mayor JL
Eur J Ophthalmol; 2020 Sep; 30(5):1034-1041. PubMed ID: 31018685
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the ab interno gelatin stent in severe pseudoexfoliation glaucoma compared to non-pseudoexfoliation glaucoma at 6 months.
Dar N; Sharon T; Hecht I; Kalev-Landoy M; Burgansky-Eliash Z
Eur J Ophthalmol; 2020 Sep; 30(5):1028-1033. PubMed ID: 31072182
[TBL] [Abstract][Full Text] [Related]
5. 1-year outcomes of the Xen45 glaucoma implant.
Smith M; Charles R; Abdel-Hay A; Shah B; Byles D; Lim LA; Rossiter J; Kuo CH; Chapman P; Robertson S
Eye (Lond); 2019 May; 33(5):761-766. PubMed ID: 30552422
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
Midha N; Gillmann K; Chaudhary A; Mermoud A; Mansouri K
J Glaucoma; 2020 Jan; 29(1):11-14. PubMed ID: 31702711
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of Standalone XEN Gel Implant and Combined Phacoemulsification-XEN Gel Implant Surgery: 1-Year Results.
Mansouri K; Guidotti J; Rao HL; Ouabas A; D'Alessandro E; Roy S; Mermoud A
J Glaucoma; 2018 Feb; 27(2):140-147. PubMed ID: 29271806
[TBL] [Abstract][Full Text] [Related]
8. Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results.
Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
J Glaucoma; 2020 Mar; 29(3):155-160. PubMed ID: 32108690
[TBL] [Abstract][Full Text] [Related]
9. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors.
Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
Acta Ophthalmol; 2021 Jun; 99(4):e531-e539. PubMed ID: 32930515
[TBL] [Abstract][Full Text] [Related]
10. XEN Gel Stent in Pseudoexfoliative Glaucoma: 2-Year Results of a Prospective Evaluation.
Gillmann K; Bravetti GE; Mermoud A; Rao HL; Mansouri K
J Glaucoma; 2019 Aug; 28(8):676-684. PubMed ID: 31162174
[TBL] [Abstract][Full Text] [Related]
11. Two-Year Outcomes of XEN Gel Stent Surgery in Patients with Open-Angle Glaucoma.
Mansouri K; Bravetti GE; Gillmann K; Rao HL; Ch'ng TW; Mermoud A
Ophthalmol Glaucoma; 2019; 2(5):309-318. PubMed ID: 32672673
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
[TBL] [Abstract][Full Text] [Related]
14. Prospective Evaluation of XEN Gel Implant in Eyes With Pseudoexfoliative Glaucoma.
Mansouri K; Gillmann K; Rao HL; Guidotti J; Mermoud A
J Glaucoma; 2018 Oct; 27(10):869-873. PubMed ID: 30095603
[TBL] [Abstract][Full Text] [Related]
15. Real-World Retrospective Consecutive Study of Ab Interno XEN 45 Gel Stent Implant with Mitomycin C in Black and Afro-Latino Patients with Glaucoma: 40% Required Secondary Glaucoma Surgery at 1 Year.
Laroche D; Nkrumah G; Ng C
Middle East Afr J Ophthalmol; 2019; 26(4):229-234. PubMed ID: 32153335
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Ollikainen ML; Puustjärvi TJ; Rekonen PK; Uusitalo HM; Teräsvirta ME
Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation.
Wałek E; Przeździecka-Dołyk J; Helemejko I; Misiuk-Hojło M
Int Ophthalmol; 2020 Jan; 40(1):235-246. PubMed ID: 31578662
[TBL] [Abstract][Full Text] [Related]
18. Early Postoperative Intraocular Pressure is Associated With Better Pressure Control After XEN Implantation.
Cutolo CA; Iester M; Bagnis A; Bonzano C; Negri L; Olivari S; Cappelli F; Testa V; Sindaco D; Pizzorno C; Scotto R; Saccheggiani M; Traverso CE
J Glaucoma; 2020 Jun; 29(6):456-460. PubMed ID: 32205829
[TBL] [Abstract][Full Text] [Related]
19. XEN Gel Stent to Treat ICE Syndrome: 4 Cases.
Lin MM; Morgan WH; Kolomeyer NN; Moster SJ; Zheng CX; Giubilato A; Moster MR
J Glaucoma; 2019 Dec; 28(12):1090-1094. PubMed ID: 31425336
[TBL] [Abstract][Full Text] [Related]
20. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
